180 related articles for article (PubMed ID: 31614566)
41. Identification and characterization of a novel botulinum neurotoxin.
Zhang S; Masuyer G; Zhang J; Shen Y; Lundin D; Henriksson L; Miyashita SI; Martínez-Carranza M; Dong M; Stenmark P
Nat Commun; 2017 Aug; 8():14130. PubMed ID: 28770820
[TBL] [Abstract][Full Text] [Related]
42. Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A).
Kalb SR; Baudys J; Raphael BH; Dykes JK; Lúquez C; Maslanka SE; Barr JR
Anal Chem; 2015 Apr; 87(7):3911-7. PubMed ID: 25731972
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25.
Lawrence GW; Ovsepian SV; Wang J; Aoki KR; Dolly JO
Neuropharmacology; 2013 Jul; 70():287-95. PubMed ID: 23485402
[TBL] [Abstract][Full Text] [Related]
44. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
45. Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B.
Wang J; Zurawski TH; Bodeker MO; Meng J; Boddul S; Aoki KR; Dolly JO
Biochem J; 2012 May; 444(1):59-67. PubMed ID: 22360156
[TBL] [Abstract][Full Text] [Related]
46. Importance of two adjacent C-terminal sequences of SNAP-25 in exocytosis from intact and permeabilized chromaffin cells revealed by inhibition with botulinum neurotoxins A and E.
Lawrence GW; Foran P; Mohammed N; DasGupta BR; Dolly JO
Biochemistry; 1997 Mar; 36(11):3061-7. PubMed ID: 9115981
[TBL] [Abstract][Full Text] [Related]
47. Association of botulinum neurotoxin serotype A light chain with plasma membrane-bound SNAP-25.
Chen S; Barbieri JT
J Biol Chem; 2011 Apr; 286(17):15067-72. PubMed ID: 21378164
[TBL] [Abstract][Full Text] [Related]
48. Mechanism of substrate recognition by the novel Botulinum Neurotoxin subtype F5.
Guo J; Chan EW; Chen S
Sci Rep; 2016 Jan; 6():19875. PubMed ID: 26794648
[TBL] [Abstract][Full Text] [Related]
49. Dynamics of SNARE assembly and disassembly during sperm acrosomal exocytosis.
De Blas GA; Roggero CM; Tomes CN; Mayorga LS
PLoS Biol; 2005 Oct; 3(10):e323. PubMed ID: 16131227
[TBL] [Abstract][Full Text] [Related]
50. SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E.
Agarwal R; Swaminathan S
J Biol Chem; 2008 Sep; 283(38):25944-51. PubMed ID: 18658150
[TBL] [Abstract][Full Text] [Related]
51. Development of immunodetection system for botulinum neurotoxin serotype E.
Sarita R; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
Indian J Med Res; 2018 Jun; 147(6):603-610. PubMed ID: 30168493
[TBL] [Abstract][Full Text] [Related]
52. Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission.
Zanetti G; Sikorra S; Rummel A; Krez N; Duregotti E; Negro S; Henke T; Rossetto O; Binz T; Pirazzini M
PLoS Pathog; 2017 Aug; 13(8):e1006567. PubMed ID: 28800600
[TBL] [Abstract][Full Text] [Related]
53. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
[TBL] [Abstract][Full Text] [Related]
54. The osmolyte trimethylamine N-oxide (TMAO) increases the proteolytic activity of botulinum neurotoxin light chains A, B, and E: implications for enhancing analytical assay sensitivity.
Nuss JE; Wanner LM; Tressler LE; Bavari S
J Biomol Screen; 2010 Sep; 15(8):928-36. PubMed ID: 20720092
[TBL] [Abstract][Full Text] [Related]
55. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release.
Foran P; Lawrence GW; Shone CC; Foster KA; Dolly JO
Biochemistry; 1996 Feb; 35(8):2630-6. PubMed ID: 8611567
[TBL] [Abstract][Full Text] [Related]
56. [Clostridium botulinum and botulinum neurotoxin].
Hirai Y
Brain Nerve; 2011 Jul; 63(7):755-61. PubMed ID: 21747146
[TBL] [Abstract][Full Text] [Related]
57. Botulinum Neurotoxin F Subtypes Cleaving the VAMP-2 Q
Sikorra S; Skiba M; Dorner MB; Weisemann J; Weil M; Valdezate S; Davletov B; Rummel A; Dorner BG; Binz T
Toxins (Basel); 2018 Aug; 10(8):. PubMed ID: 30071628
[TBL] [Abstract][Full Text] [Related]
58. Molecular targets of botulinum toxin at the mammalian neuromuscular junction.
Whelchel DD; Brehmer TM; Brooks PM; Darragh N; Coffield JA
Mov Disord; 2004 Mar; 19 Suppl 8():S7-S16. PubMed ID: 15027049
[TBL] [Abstract][Full Text] [Related]
59. Exploration of endogenous substrate cleavage by various forms of botulinum neurotoxins.
Guo J; Wang J; Chan EW; Chen S
Toxicon; 2015 Jun; 100():42-5. PubMed ID: 25912942
[TBL] [Abstract][Full Text] [Related]
60. A SNAP-25 cleaving chimera of botulinum neurotoxin /A and /E prevents TNFα-induced elevation of the activities of native TRP channels on early postnatal rat dorsal root ganglion neurons.
Nugent M; Yusef YR; Meng J; Wang J; Dolly JO
Neuropharmacology; 2018 Aug; 138():257-266. PubMed ID: 29906413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
